Literature DB >> 31792598

A landmark-based 3D analysis reveals a narrower tibial plateau and patella in trochlear dysplastic knees.

Wouter Peeters1, Annemieke Van Haver2, Sander Van den Wyngaert3, Peter Verdonk4,5.   

Abstract

PURPOSE: The trochlear dysplastic femur has a specific morphotype previously characterised by not only dysplastic features of the trochlea but also by specific features of the notch and posterior femur. In this study the morphology of the tibia and patella was investigated to gain further insight in the complete geometrical complexity of the trochlear dysplastic knee.
METHODS: Arthro-CT scan-based 3D models of 20 trochlear dysplastic and 20 normal knees were uniformly scaled and landmarks and landmark-based reference planes were created to quantify a series of morphometric characteristics of the tibia and patella.
RESULTS: In the mediolateral direction, the 3D-analysis revealed a 3% smaller medial tibial plateau (30.4 ± 1.6 mm vs 31.5 ± 1.6 mm), a 3% smaller overall width of the tibial plateau (73.6 ± 2.0 mm vs 75.7 ± 2.0 mm), a 16% smaller medial facet (17.3 ± 2.2 mm vs 20.1 ± 1.3 mm) and a 4% smaller overall width of the patella (41.7 ± 2.5 mm vs 43.4 ± 2.3 mm) in trochlear dysplastic knees. In the anteroposterior direction, the lateral tibial plateau of trochlear dysplastic knees was 5% larger (37.2 ± 2.3 mm vs 35.5 ± 3.1 mm). A correlation test between the width of the femur and the width of the tibia revealed that trochlear dysplastic knees show less correspondence between the femur and tibia compared to normal knees.
CONCLUSION: Significant differences in the morphology of the tibial plateau and patella were detected between trochlear dysplastic and normal knees. Both in the trochlear dysplastic tibial plateau and patella a narrower medial compartment leads to a significant smaller overall mediolateral width. These findings are important for the understanding of knee biomechanics and the design of total knee arthroplasty components. LEVEL OF EVIDENCE: III.

Entities:  

Keywords:  Measurements; Morphology; Patella; Patellofemoral joint; Three dimensional; Tibia; Trochlear dysplasia

Mesh:

Year:  2019        PMID: 31792598     DOI: 10.1007/s00167-019-05802-x

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  2 in total

1.  Patellofemoral morphology measurements and their associations with tibiofemoral osteoarthritis-related structural damage: exploratory analysis on the osteoarthritis initiative.

Authors:  Arya Haj-Mirzaian; Ali Guermazi; Farhad Pishgar; Frank W Roemer; Christopher Sereni; Michael Hakky; Bashir Zikria; Shadpour Demehri
Journal:  Eur Radiol       Date:  2019-07-11       Impact factor: 5.315

2.  Principal component analysis as a tool for determining optimal tibial baseplate geometry in modern TKA design.

Authors:  S Huijs; T Huysmans; A De Jong; N Arnout; J Sijbers; J Bellemans
Journal:  Acta Orthop Belg       Date:  2018-12       Impact factor: 0.500

  2 in total
  3 in total

Review 1.  Sexual dimorphism and racial diversity render bone-implant mismatch inevitable after off-the-shelf total knee arthroplasty: a systematic review and meta-analysis.

Authors:  Lucas Beckers; Jacobus H Müller; Jeremy Daxhelet; Mo Saffarini; Tarik Aït-Si-Selmi; Michel P Bonnin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-01-29       Impact factor: 4.342

2.  Patellar shape is associated with femoral trochlear morphology in individuals with mature skeletal development.

Authors:  Lanyu Qiu; Jia Li; Bo Sheng; Haitao Yang; Zhibo Xiao; Fajin Lv; Furong Lv
Journal:  BMC Musculoskelet Disord       Date:  2022-01-17       Impact factor: 2.362

3.  Small medial femoral condyle morphotype is associated with medial compartment degeneration and distinct morphological characteristics: a comparative pilot study.

Authors:  Jonas Grammens; Annemieke Van Haver; Femke Danckaers; Brian Booth; Jan Sijbers; Peter Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-14       Impact factor: 4.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.